1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
Respiratory Inhalers Market Report 2021-2031

Respiratory Inhalers Market Report 2021-2031

  • February 2021
  • 748 pages
  • ID: 6061856
  • Format: PDF
  • Visiongain

Summary

Table of Contents

Forecasts by Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Others Respiratory Disease), by Inhaler Type (Standard Pressurized Metered-dose Inhalers, Breath-actuated Pressurized Metered-dose Inhalers, Metered-dose Inhaler with a Spacer, Dry Powder Inhalers, Soft Mist Inhalers, Other Inhaler Type), by Mode of Operation (Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices, Other Mode of Operation), by Class (ICS, SABA+ICS, SABA, LABA, LAMA, ULABA, SABA+SAM A, LABA+LAM, A+ICS, SAMA, Other Class) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Respiratory Inhaler Companies AND COVID-19 Recovery Scenarios

Want to Know What is holding you back in the Respiratory Inhalers Business?
Visiongain, a renowned market intelligence firm has published strategic report on ’Respiratory Inhalers Market’. This report explores the current and emerging opportunities in the respiratory inhaler market, Non-communicable diseases (NCDs) are emerging as a major global public health problem and asthma is an important component of this group of diseases, particularly with regard to morbidity, but its importance is being ignored and neglected. One of the most complex medical devices manufactured by the pharmaceutical industry is asthma inhalers, also known as "pressurised metric dosage inhalers" (pMDIs).
Which Factors Are Driving the Global Market for Respiratory Inhalers?
The growing prevalence of respiratory diseases due to urbanization and rising pollution levels, changing lifestyles (such as lack of exercise), high prevalence of tobacco smoking, and a rapidly expanding geriatric population are pushing the smart inhalers market’s growth. Also, pandemics like 2019 novel coronavirus (COVID-19) are driving the global demand for respiratory inhalers.

Our 740+ page report provides 497 tables, 486 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing respiratory inhalers market. Buy our report to see how to exploit these opportunities in the global market.
Forecasts to 2031 and other analyses reveal the commercial prospects
. In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
. You find original analyses, with business outlooks and developments.
. Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), Porter’s Five Forces Analysis, product profiles and commercial developments.
Discover sales predictions for the global respiratory inhalers market and submarkets
Along with revenue prediction for the overall world market, there are 7 segmentations of the respiratory inhalers market, with forecasts for 5 disease type, 6 inhaler types, 3 Mode Of Operation, 10 class each forecasted at a global, regional, and country level, along with COVID-19 impact recovery pattern analysis for all segments.
Leading companies and the potential for market growth
As per the analysis, global respiratory inhalers market is estimated to be valued at US$x billion in 2021 and in terms of volume 106 million units in 2021. The market is projected to reach at a market value of US$x billion by 2031. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
What all Segments Are Covered in the Report?
Global Respiratory Inhalers Market by Disease Indication (COVID-19 Impact Recovery Analysis Covered)
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Pulmonary Arterial Hypertension
- Others Respiratory Disease

Global Respiratory Inhalers Market by Inhaler Type (COVID-19 Impact Recovery Analysis Covered)
- Standard Pressurized Metered-Dose Inhalers
- Breath-Actuated Pressurized Metered-Dose Inhalers
- Metered-Dose Inhaler with a Spacer
- Dry Powder Inhalers
- Soft Mist Inhalers
- Other Inhaler Type

Global Respiratory Inhalers Market by Mode Of Operation (COVID-19 Impact Recovery Analysis Covered)
- Manually Operated Inhaler Devices
- Digitally Operated Inhaler Devices
- Other Mode Of Operation

Global Respiratory Inhalers Market by Class (COVID-19 Impact Recovery Analysis Covered)
- ICS
- SABA+ICS
- SABA
- LABA
- LAMA
- ULABA
- SABA+SAMA
- LABA+LAMA+ICS
- SAMA
- Other Class

Global Respiratory Inhalers Market by Region (COVID-19 Impact Recovery Analysis Covered)
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East
- Africa

The global market for respiratory inhalers is ascending and has made significant gains. The players in the respiratory inhalers market are striving to tap the opportunities that this market offers. Companies are trying to explore the available prospects by adopting various strategies such as:
. Mergers and acquisitions.
. Product launches.
. Collaborations and partnerships.
Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Feb 2021.
How the Respiratory Inhalers Market report helps you? Buy this report to find answers for below questions and how can help you to stay updated
. What is the current size of the overall global respiratory inhalers market? How much will this market be worth from 2021 to 2031?
. How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031?
. Who are the leading companies and what are their activities, results, developments and prospects?
. What are some of the most prominent respiratory inhalers currently in development?
. What are the main trends that will affect the world respiratory inhalers market between 2021 and 2031?
. What are the main strengths, weaknesses, opportunities and threats for the market?
. What are the social, technological, economic and political influences that will shape that industry over the next ten years?
. How will the global respiratory inhalers market evolve over the forecasted period, 2021 to 2031?
. Which segment can succeed and what revenues could they generate to 2031?
. What will be the main commercial drivers for the market from 2021 to 2031?
. How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving highest revenues and fastest growth?
. How will that industry evolve between 2021 and 2031, especially in R&D?
Top 20 Leading Players Profiled in the Report
. AstraZeneca PLC
. Merck KGaA
. Cipla Limited
. GlaxoSmithKline PLC
. Beximco Pharmaceuticals Limited (BPL)
. OMRON Corporation
. Pulmatrix, Inc.
. Novartis AG
. Teva Pharmaceutical Industries Ltd
. OPKO Health, Inc.
. Recipharm publ AB
. Vectura Group plc
. Regeneron Pharmaceuticals, Inc.
. Sanofi Pasteur Pharmaceutical
. C.H. Boehringer Sohn AG & Ko. KG
. F. Hoffmann-La Roche Ltd
. Amiko Digital Health
. Merck & Co., Inc

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. This study is for everybody needing commercial analyses for the respiratory inhalers market and leading companies. You will find data, trends and predictions.


Please note: This report is accessed through a password system. Single user (non-printable) and departmental licenses expires after 12 month period.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on